High level priorities
The goal for North Tyneside is to achieve vaccination coverage levels that protect as many individuals as possible and to achieve effective herd immunity. To do this we need to tackle the inequalities in vaccine uptake.
North Tyneside should understand what action high achieving practices are taking to share positive learning across the borough.
Data indicates that timeliness of offer may be an issue within North Tyneside, and this should be considered. Timely immunisation is important to get the best immune response and to give protection at the right time.
Focused support in line with the evidence should be given to practices that are not achieving the 95% coverage levels.
There should be an understanding as to why the local/national uptake declined for flu vaccination in two- and three-year-olds to improve uptake for winter 2022/23.
North Tyneside should understand from Child Health if there are children not registered with a GP within the borough and if there is outstanding immunisation needs.
North Tyneside should understand what action the School Aged Immunisation Service are taking to reduce inequalities and improve uptake of the school aged programmes.
Consideration should be given to seek parent, carer, and young person views as to how to improve vaccine acceptance within the borough.
There is no published data available for the BCG vaccination or selective Hepatitis B programme and assurance should be sought from NHS England and Improvement as the commissioner of the service.
More broadly, North Tyneside aspires to meet the World Health Organisation international targets for immunisation:
- High coverage rates
- Equitable coverage rates
- 90% coverage for HPV vaccination
- The World Health Organization (WHO) currently recommends that on a national basis at least 95% of children are immunised against diseases preventable by immunisation and targeted for elimination or control (specifically, diphtheria, neonatal tetanus, pertussis, polio, Haemophilus influenzae type b (Hib), Hepatitis B, measles, mumps, and congenital rubella).